Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Consider viscosity appropriate to your goal: glucomannan for satiety (highly viscous), inulin for prebiotic effects (fermentable), psyllium for combined benefits
The main findings so far are dose-dependent weight loss in phase 2 studies, frequent gastrointestinal side effects, and ongoing questions about long-term safety, eligibility, and approval
This gut-specific data is part of why BPC-157 is frequently used by practitioners managing post-surgical GI recovery or irritable bowel conditions
see-how-monte-nido-approaches-co-occurring-eating-disorder-and-substance-use-treatment="/cta-buttons" Should GLP-1s Be Used for Addiction Treatment Right Now
Clinical trial data from the SURMOUNT-1 study showed that gastrointestinal adverse events were significantly more common during dose escalation periods (Jastreboff et al., 2022, NEJM)
